Botulinum Toxin Purification via Three-Step Chromatography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for purifying botulinum toxin are inefficient, yielding low purity and activity, and often require additional steps to reform biologically active botulinum toxin proteins.

Innovation Solution

A method involving cation exchange chromatography, hydrophobic chromatography, and anion exchange chromatography is used to purify botulinum toxin, achieving a purity of 99% or more using specific resins like SP, phenyl, and Q columns.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If precipitation and tangential flow filtration steps are used to purify botulinum toxin in complexed form, then the purification process is established, but the yield is low (less than 10%)

Engineering Contradiction:
ImproveyieldVSAvoidpurification effectiveness
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically adjusting pH values at different stages (pH 2.0-3.0 for cation exchange binding, pH 7.0-8.0 for anion exchange binding) and ionic strengths to optimize toxin binding and elution. This resolves the contradiction by achieving both high yield (>90%) and high purity through controlled parameter variations rather than relying on single-step precipitation methods.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent segments the purification process into three distinct chromatography steps: cation exchange chromatography, hydrophobic interaction chromatography, and anion exchange chromatography. Each step targets specific impurities while preserving the toxin, thereby achieving both high yield and high purity that cannot be obtained through single-step precipitation methods.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If size exclusion, ion exchange and/or affinity chromatography are used, then purification is achieved, but the process complexity increases

Engineering Contradiction:
ImprovepurityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges cation exchange, hydrophobic interaction, and anion exchange chromatography into a unified three-step protocol that systematically removes different classes of impurities. This integrated approach achieves comprehensive purification (99%+ purity) while maintaining operational simplicity through standardized buffer conditions and sequential processing, resolving the contradiction between purity and complexity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent uses systematic parameter changes (pH, ionic strength, buffer composition) to optimize each chromatography step for maximum toxin recovery and minimum impurity carryover. This resolves the contradiction by achieving high manufacturing precision through controlled parameter variations rather than requiring complex multi-parameter optimization.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If hydrophobic interaction chromatography and mixed-mode chromatography are used to purify botulinum toxins as complexes, then purification is achieved, but the yield and purity are insufficient

Engineering Contradiction:
ImprovepurityVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent segments impurity removal into three specialized chromatography steps, each targeting specific impurity classes: cation exchange for acidic impurities, hydrophobic interaction for hydrophobic contaminants, and anion exchange for basic impurities. This segmented approach achieves both high purity (>99%) and high yield (>90%) by addressing different impurity types separately rather than relying on single-mode chromatography.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies parameter changes including pH adjustment (2.0-3.0 for cation exchange, 7.0-8.0 for anion exchange), ionic strength variation, and buffer composition optimization to maximize toxin binding and elution at each chromatography step. This resolves the contradiction by achieving both high purity and high yield through controlled parameter variations.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method significantly improves the purity and maintains the biological activity of botulinum toxin, providing a stable and highly pure form.

Implementation Method 1

purifying the pre-treated botulinum toxin using cation exchange chromatography

Methodology Applied
Scientific EffectCation exchange chromatography: Ion Exchange

Implementation Method 2

purifying the botulinum toxin using hydrophobic chromatography

Methodology Applied
Scientific EffectHydrophobic chromatography: Hydrophobe

Implementation Method 3

purifying the botulinum toxin using anion exchange chromatography

Methodology Applied
Scientific EffectAnion exchange chromatography: Ion Exchange

Data Source

PatentUS12577551B2Method of purifying botulinum toxin
Publication Date: 2026.03.17 JETEMA CO LTD
  • US12577551B2 patent drawing
  • US12577551B2 patent drawing
  • US12577551B2 patent drawing

AI summary

Disclosed is a method of purifying a botulinum toxin comprising (a) pre-treating a culture solution containing a botulinum toxin, (b) purifying the pre-treated botulinum toxin using cation exchange chromatography, (c) purifying the botulinum toxin using hydrophobic chromatography, and (d) purifying the botulinum toxin using anion exchange chromatography. The method is capable of purifying a botulinum toxin with high purity and activity and is thus useful for botulinum toxin production.